查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2049318

心臟假體設備市場報告：按產品類型、最終用戶和地區分類（2026-2034 年）

Cardiac Prosthetic Devices Market Report by Product Type (Valves, Pacemakers, Implantable Pacemakers, External Pacemakers, and Others), End-User (Hospitals, Clinics and Cardiac Centers, Ambulatory Surgical Centers, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球心臟假體設備市場規模達76億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到133億美元，2026年至2034年的複合年成長率為6.17%。推動市場成長的主要因素包括小型心律調節器和無縫合瓣膜置換術的研發、微創手術的日益普及以及心血管疾病在一般人群中發病率的上升。

心臟假體是指用於替代或輔助心臟正常功能的人工裝置或植入。它們用於治療各種心臟疾病，包括心臟衰竭、瓣膜性心臟疾病和先天性心臟缺陷。心臟假體大致分為兩類：人工心臟瓣膜和機械循環輔助裝置。人工心臟瓣膜用於替換受損或病變的心臟瓣膜，恢復心臟的正常血流。而機械循環輔助裝置則用於輔助或替代心臟的泵血功能，通常用作心臟移植前的過渡治療，或作為不適合心臟移植患者的長期解決方案。此外，這些裝置採用生物相容性材料製成，並經過精心設計，旨在複製心臟的結構和功能，從而改善患者的心臟功能和生活品質。

全球人口老化是推動該產業發展的驅動力。隨著人口老化，心血管疾病的發生率上升，導致對人工心臟瓣膜的需求增加。此外，醫療和外科技術的不斷進步提高了心血管疾病患者的生存率，從而擴大了這些器械的適用人群。同時，大眾對心血管健康的日益重視以及治療方案的普及也促進了產品需求。患者尋求早期干預，包括使用人工心臟裝置，以改善生活品質並延長生存期，這對市場產生了積極影響。其他對市場有正面影響的因素還包括醫療領域的持續發展以及主要公司進行的大量研發活動。

心臟假體器械市場的趨勢與促進因素：

心血管疾病盛行率和公眾意識的提高

冠狀動脈疾病、心臟衰竭和瓣膜性心臟病等心血管疾病是全球範圍內導致發病率和死亡率的主要原因。此外，人們對心臟病及其預防措施的認知不斷提高，以及治療方法方案的日益豐富，使得心血管疾病的早期發現和診斷成為可能。診斷能力的提升，包括心臟超音波圖和心臟磁振造影等先進影像技術的應用，使得診斷更加精準，也更容易識別出能夠從心臟人工裝置中獲益的患者。公眾意識的提高，加上多種疾病盛行率的上升，導致對這些產品的需求不斷成長。隨著越來越多的人在心血管疾病早期得到診斷，能夠從心臟人工裝置治療中獲益的患者群體也在擴大。

引入優惠的還款政策

報銷機制在心臟假體的廣泛應用過程中發揮著至關重要的作用。公共醫療體系和私人保險公司提供的優惠報銷政策獎勵醫療服務提供者向病人提供這些設備和手術。這降低了患者的經濟負擔，促進了心臟假體的使用，從而為市場成長創造了有利環境。此外，全球醫療成本因疾病負擔加重和醫療技術進步而不斷上漲，也提高了心臟假體的價格和可近性，使其更容易被有需要的患者獲得。同時，市場參與者之間建立的夥伴關係、合作以及分銷網路也是推動市場成長的重要因素。

心臟外科手術技術和器械的持續創新

心臟外科技術的不斷進步，例如微創手術、機器人輔助手術和經導管治療，正在擴大各種心臟疾病的治療選擇範圍。這些進步促進了心臟瓣膜、心室輔助裝置（VAD）和心律調節器等產品的使用，這些產品在手術中發揮著至關重要的作用。科技的快速發展徹底改變了心臟假體的設計和功能。例如，經導管心臟瓣膜的研發使得微創瓣膜置換術成為可能，從而減輕了患者的負擔並縮短了復原時間。此外，無線連接、遠端監測功能以及將先進感測器整合到心律調節器和植入式心臟整流去顫器（ICD）中，都改善了患者照護和治療效果，從而創造了良好的市場前景。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球心臟假體市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品類型分類

  • 閥門
    • 主要類型
      • 機械閥
      • 生物瓣膜
      • 帶支架的生物瓣膜
      • 無支架生物瓣膜
      • 經導管瓣膜
  • 心律調節器
  • 植入式心臟節律器
    • 主要類型
      • 單腔電池心律調節器
      • 雙腔電池供電式心律調節器
      • 三腔電池供電式心律調節器
  • 體外心律調節器
  • 其他

第7章 市場區隔：依最終用戶分類

  • 醫院、診所、心臟中心
  • 門診手術中心
  • 其他

第8章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章 SWOT 分析

第10章：價值鏈分析

第11章：波特五力分析

第12章：價格分析

第13章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Biotronik
    • Boston Scientific Corporation
    • Edwards Lifesciences Corporation
    • Lepu Medical Technology Co. Ltd.
    • Medtronic Inc.
    • Meril Life Sciences Pvt. Ltd.
    • Siemens Healthcare GmbH
    • Sorin Group
    • St. Jude Medical Inc.
Product Code: SR112026A2037

The global cardiac prosthetic devices market size reached USD 7.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 13.3 Billion by 2034, exhibiting a growth rate (CAGR) of 6.17% during 2026-2034. The development of compact pacemakers and suture-less valve replacements, the growing inclination toward minimally invasive (MI) procedures, and the rising prevalence of cardiovascular disorders among the masses are some of the major factors propelling the market.

Cardiac prosthetic devices refer to artificial devices or implants designed to replace or assist the normal functioning of the heart. They are used in the treatment of various heart conditions, such as heart failure, valve disorders, or congenital heart defects. They can be broadly categorized into two types, artificial heart valves and mechanical circulatory support devices. Artificial heart valves are used to replace damaged or diseased heart valves, restoring normal blood flow through the heart. On the other hand, mechanical circulatory support devices are used to assist or replace the pumping function of the heart, often employed as a bridge to transplantation or as a long-term solution for patients ineligible for heart transplantation. Additionally, they are manufactured of biocompatible materials and are meticulously designed to replicate the structure and function of the heart, thereby improving the patient's cardiac function and quality of life.

The industry is driven by the aging global population. As the population continues to age, the incidence of cardiovascular diseases increases, leading to a higher demand for cardiac prosthetic devices. Additionally, continual advancements in medical technology and surgical techniques have improved the survival rates of patients with cardiovascular diseases, this is creating a larger patient pool for these devices. Along with this, the increasing awareness about cardiovascular health and the availability of treatment options among the masses is fueling the product demand. Also, patients are seeking timely interventions, including the use of cardiac prosthetic devices, to improve their quality of life and prolong survival, which is positively influencing the market. Other factors, including continual developments in the healthcare sector and extensive research and development (R&D) activities conducted by key players, are also positively influencing the market.

CARDIAC PROSTHETIC DEVICES MARKET TRENDS/DRIVERS:

Increasing Prevalence of Cardiovascular Diseases and their Awareness

Cardiovascular diseases, including coronary artery disease, heart failure, and valvular heart diseases, are significant contributors to morbidity and mortality across the globe. Additionally, the increasing awareness about heart diseases, preventive measures, and the availability of treatment options has led to earlier detection and diagnosis of cardiovascular conditions. Improved diagnostic capabilities, including advanced imaging techniques, such as echocardiography and cardiac MRI, facilitate accurate diagnosis and identification of patients who may benefit from cardiac prosthetic devices. The combination of public awareness and the rising prevalence of numerous diseases has led to an increasing product demand. As more individuals are diagnosed with CVDs at an earlier stage, there is a growing pool of patients who could benefit from interventions involving cardiac prosthetics.

The Implementation of Favorable Reimbursement Policies

Reimbursement plays a vital role in the adoption of cardiac prosthetic devices. Favorable reimbursement policies offered by government healthcare systems and private insurance providers incentivize healthcare providers to offer these devices and procedures to their patients. This creates a conducive environment for market growth, as it reduces financial barriers for patients and promotes the use of cardiac prosthetic devices. In addition, the rising disease burden, and advances in medical technology are increasing healthcare expenditure across the globe. This higher healthcare spending is contributing to the affordability and accessibility of cardiac prosthetic devices, making them more widely available to patients in need. Besides this, market players are establishing partnerships, collaborations, and distribution networks, which are acting as another growth-inducing factor.

Continual Technological Innovations in Cardiac Surgery Techniques and Devices

Continuous advancements in cardiac surgical techniques, such as minimally invasive procedures, robotic-assisted surgeries, and transcatheter interventions, have expanded the scope of treating various cardiac conditions. These advancements have increased product utilization, including heart valves, ventricular assist devices (VADs), and pacemakers, as they play a crucial role in these procedures. Rapid advancements in technology have revolutionized the design and functionality of cardiac prosthetic devices. For instance, the development of transcatheter heart valves has enabled less invasive valve replacement procedures, reducing patient trauma and recovery time. Additionally, the integration of wireless connectivity, remote monitoring capabilities, and advanced sensors in pacemakers and implantable cardioverter-defibrillators (ICDs) has improved patient care and outcomes, creating a positive market outlook.

CARDIAC PROSTHETIC DEVICES INDUSTRY SEGMENTATION:

Breakup by Product Type:

  • Valves
    • Mechanical Valve
    • Tissue Valve
    • Stented Tissue Valve
    • Stentless Tissue Valve
    • Transcatheter Valve
  • Pacemakers
  • Implantable Pacemakers
    • Single-Chamber Battery Pacemaker
    • Dual-Chamber Battery Pacemaker
    • Triple-Chamber Battery Pacemaker
  • External Pacemakers
  • Others

Valves dominate the market

Continual technological advancements in valve design and materials have improved the durability, functionality, and overall performance of devices, leading to greater acceptance and adoption. Additionally, the increasing focus on minimally invasive procedures and the development of transcatheter heart valve replacement techniques are positively influencing the demand for valve products.

Additionally, continuous advancements in medical technology have led to the development of innovative pacemaker devices with improved features and functionalities, including wireless connectivity and remote monitoring capabilities, which further drive market growth. Moreover, the rising prevalence of lifestyle-related diseases, such as obesity and diabetes, which are risk factors for heart ailments, is fueling the demand for pacemakers across the globe.

Breakup by End-User:

  • Hospitals, Clinics and Cardiac Centers
  • Ambulatory Surgical Centers
  • Others

Hospitals, clinics and cardiac centers hold the largest share in the market

The increasing usage of these devices in hospitals, clinics, and cardiac centers can be attributed to the continual advancements in medical technology and surgical techniques. The continuous development of innovative devices, such as artificial heart valves and implantable pacemakers, enables healthcare providers to offer improved treatment options to patients. Furthermore, various government initiatives and healthcare reforms aimed at enhancing cardiovascular care and improving patient outcomes also serve as major market drivers for the end-users in the industry.

On the contrary, ambulatory surgical centers (ASCs) as end-users in the cardiac offer numerous advantages, such as cost-effectiveness, convenience, and reduced hospital stays, which are particularly appealing to patients seeking cardiac procedures. These centers provide a suitable environment for minimally invasive surgeries and outpatient treatments, aligning with the growing trend towards value-based healthcare. Additionally, advancements in technology have made it feasible to perform complex cardiac procedures in ASCs, further fueling the market demand in this segment over the forecast period.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest the cardiac prosthetic devices market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

The market in North America is driven by the increasing prevalence of cardiovascular diseases and the growing aging population. As heart-related conditions become more common, the need for devices such as heart valves, pacemakers, and implantable defibrillators is growing. Additionally, the healthcare system across the region focuses on quality healthcare delivery and reimbursement support for medical devices also plays a significant role in the growth of the market. Moreover, research and development efforts aimed at developing innovative and minimally invasive prosthetic devices are significantly supporting the market.

On the contrary, Asia Pacific is estimated to expand further in this domain in the coming years due to the aging population and changing lifestyles. In confluence with this, advancements in healthcare infrastructure and the rising disposable income in several countries within the Asia Pacific region have improved access to medical treatments and increased affordability. Furthermore, ongoing technological advancements and innovations in the field are driving the market in Asia Pacific.

COMPETITIVE LANDSCAPE:

The market is experiencing significant growth due to the continual advancements in medical technology and surgical procedures leading to the development of innovative and more efficient devices. Additionally, the integration of digital health technologies is creating opportunities for companies to offer remote monitoring solutions and personalized healthcare services, enhancing patient outcomes and increasing the overall value proposition of their products. Also, numerous companies are developing tailored solutions to address specific patient needs, this is gaining prominence across the globe. Moreover, the development of 3D printing technology has further facilitated the production of patient-specific devices, allowing for better fit and improved functionality. Additionally, top companies are investing in research and development to create customizable solutions and collaborate with healthcare professionals to understand patient requirements, which is influencing the market.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbott Laboratories
  • Biotronik
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Lepu Medical Technology Co. Ltd.
  • Medtronic Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Siemens Healthcare GmbH
  • Sorin Group
  • St. Jude Medical Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global cardiac prosthetic devices market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global cardiac prosthetic devices market?
  • What is the impact of each driver, restraint, and opportunity on the global cardiac prosthetic devices market?
  • What are the key regional markets?
  • Which countries represent the most attractive cardiac prosthetic devices market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the cardiac prosthetic devices market?
  • What is the breakup of the market based on the end-user?
  • Which is the most attractive end-user in the cardiac prosthetic devices market?
  • What is the competitive structure of the global cardiac prosthetic devices market?
  • Who are the key players/companies in the global cardiac prosthetic devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cardiac Prosthetic Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Valves
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Mechanical Valve
      • 6.1.2.2 Tissue Valve
      • 6.1.2.3 Stented Tissue Valve
      • 6.1.2.4 Stentless Tissue Valve
      • 6.1.2.5 Transcatheter Valve
    • 6.1.3 Market Forecast
  • 6.2 Pacemakers
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Implantable Pacemakers
    • 6.3.1 Market Trends
    • 6.3.2 Major Types
      • 6.3.2.1 Single-Chamber Battery Pacemaker
      • 6.3.2.2 Dual-Chamber Battery Pacemaker
      • 6.3.2.3 Triple-Chamber Battery Pacemaker
    • 6.3.3 Market Forecast
  • 6.4 External Pacemakers
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by End-User

  • 7.1 Hospitals, Clinics and Cardiac Centers
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Ambulatory Surgical Centers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 Biotronik
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Boston Scientific Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Edwards Lifesciences Corporation
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Lepu Medical Technology Co. Ltd.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Medtronic Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Meril Life Sciences Pvt. Ltd.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Siemens Healthcare GmbH
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Sorin Group
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 St. Jude Medical Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Cardiac Prosthetic Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Cardiac Prosthetic Devices Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Cardiac Prosthetic Devices Market: Breakup by Product Type (in %), 2025
  • Figure 4: Global: Cardiac Prosthetic Devices Market: Breakup by End-User (in %), 2025
  • Figure 5: Global: Cardiac Prosthetic Devices Market: Breakup by Region (in %), 2025
  • Figure 6: Global: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 7: Global: Cardiac Prosthetic Devices (Valves) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Cardiac Prosthetic Devices (Valves) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Cardiac Prosthetic Devices (Pacemakers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Cardiac Prosthetic Devices (Pacemakers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Cardiac Prosthetic Devices (Implantable Pacemakers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Cardiac Prosthetic Devices (Implantable Pacemakers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Cardiac Prosthetic Devices (External Pacemakers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Cardiac Prosthetic Devices (External Pacemakers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Cardiac Prosthetic Devices (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Cardiac Prosthetic Devices (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Cardiac Prosthetic Devices (Hospitals, Clinics and Cardiac Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Cardiac Prosthetic Devices (Hospitals, Clinics and Cardiac Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Cardiac Prosthetic Devices (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Cardiac Prosthetic Devices (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Cardiac Prosthetic Devices (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Cardiac Prosthetic Devices (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: North America: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: North America: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: United States: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: United States: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Canada: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Canada: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Asia Pacific: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Asia Pacific: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: China: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: China: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Japan: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Japan: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: India: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: India: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: South Korea: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: South Korea: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Australia: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Australia: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Indonesia: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Indonesia: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Others: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Others: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Europe: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Europe: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Germany: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Germany: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: France: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: France: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: United Kingdom: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: United Kingdom: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Italy: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Italy: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Spain: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Spain: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Russia: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Russia: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Others: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Others: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Latin America: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Latin America: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Brazil: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Brazil: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Mexico: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Mexico: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Others: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Others: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Middle East and Africa: Cardiac Prosthetic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Middle East and Africa: Cardiac Prosthetic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Global: Cardiac Prosthetic Devices Industry: SWOT Analysis
  • Figure 72: Global: Cardiac Prosthetic Devices Industry: Value Chain Analysis
  • Figure 73: Global: Cardiac Prosthetic Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cardiac Prosthetic Devices Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Cardiac Prosthetic Devices Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Cardiac Prosthetic Devices Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 4: Global: Cardiac Prosthetic Devices Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Cardiac Prosthetic Devices Market: Competitive Structure
  • Table 6: Global: Cardiac Prosthetic Devices Market: Key Players